Hudson Bay Capital Management Portfolio holdings
AUM
$15.2B
1-Year Return
11.47%
This Quarter Return
+7.71%
1 Year Return
+11.47%
3 Year Return
+62.45%
5 Year Return
+105.91%
10 Year Return
+214.7%
AUM
$15.2B
AUM Growth
-$567M
(-3.6%)
Cap. Flow
-$4.01B
Cap. Flow
% of AUM
-26.38%
Top 10 Holdings %
Top 10 Hldgs %
30.45%
Holding
1,273
New
361
Increased
234
Reduced
239
Closed
292
Top Buys
| 1 |
Amazon
AMZN
|
+$191M |
| 2 |
Strategy Inc Common Stock Class A
MSTR
|
+$190M |
| 3 |
Advanced Micro Devices
AMD
|
+$166M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$145M |
| 5 |
Target
TGT
|
+$122M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$497M |
| 2 |
Coinbase
COIN
|
+$371M |
| 3 |
Apple
AAPL
|
+$339M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$259M |
| 5 |
Microsoft
MSFT
|
+$254M |
Sector Composition
| 1 | Technology | 21.96% |
| 2 | Consumer Discretionary | 14.94% |
| 3 | Financials | 13.97% |
| 4 | Healthcare | 8.46% |
| 5 | Real Estate | 6.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
676
HCA Healthcare
HCA
$96.7B
| $706K | ﹤0.01% |
1,844
+394
| +27% | +$151K |
|
677
Snap
SNAP
$12.3B
| $695K | ﹤0.01% |
80,000
+40,973
| +105% | +$356K |
|
678
Janux Therapeutics
JANX
$1.43B
| $693K | ﹤0.01% |
30,000
-80,000
| -73% | -$1.85M |
|
679
Hamilton Lane
HLNE
$6.49B
| $671K | ﹤0.01% |
+4,720
| New | +$671K |
|
680
Larimar Therapeutics
LRMR
$331M
| $661K | ﹤0.01% |
+228,761
| New | +$661K |
|
|
LENZ
681
LENZ Therapeutics
LENZ
$1.14B
| $654K | ﹤0.01% |
+22,313
| New | +$654K |
|
682
First Citizens BancShares
FCNCA
$25.1B
| $644K | ﹤0.01% |
+329
| New | +$644K |
|
683
ACM Research
ACMR
$1.79B
| $636K | ﹤0.01% |
+24,570
| New | +$636K |
|
684
Ferrari
RACE
$85.4B
| $629K | ﹤0.01% |
+1,283
| New | +$629K |
|
685
Iron Mountain
IRM
$28.6B
| $626K | ﹤0.01% |
+6,108
| New | +$626K |
|
686
Deere & Co
DE
$129B
| $618K | ﹤0.01% |
1,216
+46
| +4% | +$23.4K |
|
687
Centene
CNC
$15.3B
| $617K | ﹤0.01% |
11,362
+7,612
| +203% | +$413K |
|
688
Prologis
PLD
$104B
| $615K | ﹤0.01% |
5,851
+3,831
| +190% | +$403K |
|
689
Coherus Oncology, Inc. Common Stock
CHRS
$157M
| $611K | ﹤0.01% |
835,000
| – | – |
|
690
American International
AIG
$43.5B
| $611K | ﹤0.01% |
7,134
-7,416
| -51% | -$635K |
|
691
Markel Group
MKL
$24.4B
| $609K | ﹤0.01% |
+305
| New | +$609K |
|
692
Corcept Therapeutics
CORT
$7.56B
| $597K | ﹤0.01% |
+8,140
| New | +$597K |
|
|
VOYG
693
Voyager Technologies, Inc.
VOYG
$1.69B
| $589K | ﹤0.01% |
+15,000
| New | +$589K |
|
694
Match Group
MTCH
$9.19B
| $577K | ﹤0.01% |
+18,680
| New | +$577K |
|
695
Raymond James Financial
RJF
$33B
| $554K | ﹤0.01% |
+3,609
| New | +$554K |
|
|
CEPT
696
Cantor Equity Partners II, Inc. Class A Ordinary Share
CEPT
$320M
| $552K | ﹤0.01% |
+50,000
| New | +$552K |
|
697
Zoom
ZM
$25.6B
| $551K | ﹤0.01% |
+7,060
| New | +$551K |
|
|
TGI
698
DELISTED
Triumph Group
TGI
| $550K | ﹤0.01% |
21,378
-20,118
| -48% | -$518K |
|
699
Cigna
CI
$80.6B
| $541K | ﹤0.01% |
1,637
-403
| -20% | -$133K |
|
700
Verisk Analytics
VRSK
$37.5B
| $535K | ﹤0.01% |
1,716
+886
| +107% | +$276K |
|